Encouraging Start for New HCV Treatment Concept
December 11, 2009
New Hepatitis C Treatment Shows Promise
Drug prevented virus from replicating in the livers of primates
By Jennifer Thomas
THURSDAY, Dec. 3 (HealthDay News) — A new drug to treat hepatitis C has shown promise in a primate study.
The drug, called SPC3649, uses a new strategy to prevent the hepatitis C virus from replicating. Unlike other antivirals that target the virus itself, the new DNA-based drug targets a small RNA molecule in the liver that hepatitis C needs to replicate, the researchers explained.
By inhibiting the molecule, SPC3649 reduced hepatitis C virus levels in the liver and in the bloodstream in chimpanzees that received the highest dose by 350-fold.
Continue reading the entire article:
Could Vitamin D Be the Missing Ingredient in HCV Therapy?
Hep C Discrimination in the Workplace